Possible efficacy of lamivudine treatment to prevent hepatitis B virus reactivation due to rituximab therapy in a patient with non-Hodgkin's lymphoma

By Tsutsumi Y.  

Annals of Hematology, Vol. 83, Iss. 1, 2004-01 ,pp. : 58-60

Springer Publishing Company

Access to resources Recommend Favorite

Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP

By Dai Ming-Shen   Chao Tsu-Yi   Kao Woei-Yau   Shyu Rong-Yaun   Liu Tan-Mei  

Annals of Hematology, Vol. 83, Iss. 12, 2004-12 ,pp. : 769-774

Springer Publishing Company

Access to resources Recommend Favorite

The effectiveness of lamivudine in preventing hepatitis B viral reactivation in rituximab-containing regimen for lymphoma

By He Yi-Fu  

Annals of Hematology, Vol. 87, Iss. 6, 2008-06 ,pp. : 481-485

Springer Publishing Company

Access to resources Recommend Favorite

Safe vaccination against hepatitis B virus and discontinuation of hepatitis B immune globulin treatment in a liver transplanted patient

By Weiss P.  

Transplantation Proceedings, Vol. 32, Iss. 4, 2000-06 ,pp. : 712-713

Elsevier

Access to resources Recommend Favorite

Rituximab in the treatment of diffuse large B-cell lymphoma primary of the lung

By Aviles Agustin   Nambo Maria J.   Huerta-Guzman Judith   Silva Luis   Neri Natividad  

Hematology, Vol. 18, Iss. 2, 2013-03 ,pp. : 81-84

Maney Publishing

Access to resources Recommend Favorite